Cahill Represents Financing Sources in Senior Notes Offering and Credit Facility for 21st Century Oncology
Cahill represented Morgan Stanley, Deutsche Bank Securities, KeyBanc Capital Markets, and HSBC as joint book-running managers in connection with the Rule 144A offering of $360,000,000 aggregate principal amount of 11% Senior Notes due 2023 by 21st Century Oncology, Inc., a leading global, physician-led provider of integrated cancer care services. Proceeds from the offering were used for general corporate purposes and to refinance existing indebtedness.
Cahill also represented Morgan Stanley Senior Funding as administrative agent and lead arranger in connection with a $610,000,000 Term B loan, and a $125,000,000 revolving credit agreement for 21st Century Oncology. Proceeds were also used for general corporate purposes and to refinance existing indebtedness.